BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4877739)

  • 21. Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice.
    Aoki T; Boyse EA; Old LJ
    J Natl Cancer Inst; 1968 Jul; 41(1):89-96. PubMed ID: 4880891
    [No Abstract]   [Full Text] [Related]  

  • 22. Immune complexes in mice infected neonatally with Moloney leukaemogenic and murine sarcoma viruses.
    Hirsch MS; Allison AC; Harvey JJ
    Nature; 1969 Aug; 223(5207):739-40. PubMed ID: 4308421
    [No Abstract]   [Full Text] [Related]  

  • 23. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus-coded antigens in chemically induced leukemia.
    Pasternak G; Pasternak L
    Boll Ist Sieroter Milan; 1971; 50(3):192-8. PubMed ID: 5004411
    [No Abstract]   [Full Text] [Related]  

  • 25. Monoclonal antibodies to the envelope proteins of Moloney leukemia virus: characterization of recombinant viruses.
    Cicurel L; Lee JC; Enjuanes L; Ihle JN
    Transplant Proc; 1980 Sep; 12(3):394-7. PubMed ID: 7222218
    [No Abstract]   [Full Text] [Related]  

  • 26. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens.
    Fenyö EM; Klein E; Klein G; Swiech K
    J Natl Cancer Inst; 1968 Jan; 40(1):69-89. PubMed ID: 4864597
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative assay of Moloney leukemia virus and Rauscher leukemia virus by immunofluorescence in cell culture.
    Pinkel D; Yoshida K
    Bibl Haematol; 1968; 30():89-91. PubMed ID: 4877329
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1967 Oct; 27(10):1743-8. PubMed ID: 6064953
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody response and leukemia development in mice inoculated neonatally with the Moloney virus.
    Klein E; Klein G
    Cancer Res; 1965 Jul; 25(6):851-4. PubMed ID: 4284254
    [No Abstract]   [Full Text] [Related]  

  • 31. Study of the antigenic specificity of Graffi leukemic cells.
    Levy JP; Leclerc JC; Varet B; Oppenheim E
    J Natl Cancer Inst; 1968 Sep; 41(3):743-50. PubMed ID: 4300309
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiviral effects of amino acid derivatives with the fluorene substituent on murine leukemia viruses.
    Fujita H; Toyoshima S
    J Natl Cancer Inst; 1983 Feb; 70(2):275-8. PubMed ID: 6571936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice.
    Fefer A; McCoy JL; Perk K; Glynn JP
    Cancer Res; 1968 Aug; 28(8):1577-85. PubMed ID: 4876979
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VII. Kinetic studies on various parameters of effects induced with suppressor cells.
    Deutsch O; Devens B; Naor D
    Isr J Med Sci; 1980 Jul; 16(7):530-7. PubMed ID: 6447122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the neutralization of the oncogenicity of Friend, Moloney, and Rauscher viruses.
    McCoy JL; Fefer A; Glynn JP
    Cancer Res; 1968 May; 28(5):942-6. PubMed ID: 4870883
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective immunoglobulin deficiencies in rats infected with Moloney virus.
    Cremer NE
    J Immunol; 1967 Jul; 99(1):71-81. PubMed ID: 4166025
    [No Abstract]   [Full Text] [Related]  

  • 37. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
    Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ
    J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
    Weiss A; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis.
    Grönberg A; Kiessling R; Eriksson E; Hansson M
    J Immunol; 1981 Nov; 127(5):1734-9. PubMed ID: 6975295
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acomparative study of antigenic properties of cells from murine leukemia of Mazurenko, Friend, Rauscher and Graffi by the method of fluorescent antibodies].
    Dirlugian RP; Stepina VN
    Vestn Akad Med Nauk SSSR; 1966; 21(9):7-12. PubMed ID: 4874531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.